{"id":"treximet","rwe":[],"tags":[],"safety":{"boxedWarnings":["WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS See full prescribing information for complete boxed warning. Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. ( 5.1 ) TREXIMET is contraindicated in the set"],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Somnolence","drugRate":"","severity":"common","organSystem":""},{"effect":"Chest discomfort/chest pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Neck/throat/jaw pain/tightness/pressure","drugRate":"","severity":"common","organSystem":""},{"effect":"Paresthesia","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"","severity":"common","organSystem":""},{"effect":"Dry mouth","drugRate":"","severity":"common","organSystem":""},{"effect":"Hot flush","drugRate":"","severity":"common","organSystem":""},{"effect":"Muscle tightness","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Cardiovascular Thrombotic Events","drugRate":"","severity":"serious"},{"effect":"GI Bleeding, Ulceration and Perforation","drugRate":"","severity":"serious"},{"effect":"Arrhythmias","drugRate":"","severity":"serious"},{"effect":"Cerebrovascular Events","drugRate":"","severity":"serious"},{"effect":"Other Vasospasm Reactions","drugRate":"","severity":"serious"},{"effect":"Hepatotoxicity","drugRate":"","severity":"serious"},{"effect":"Anaphylactic Reactions","drugRate":"","severity":"serious"},{"effect":"Serious Skin Reactions","drugRate":"","severity":"serious"},{"effect":"Serotonin Syndrome","drugRate":"","severity":"serious"},{"effect":"Seizures","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL128","moleculeType":"Small molecule","molecularWeight":"295.41"},"aliases":["Sumatriptan succinate 85mg/Naproxen Sodium 500mg","The brand name of sumatriptan/naproxen sodium is Treximet.","Imitrex and Naproxen Sodium","Sumatriptan/Naproxen Sodium"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"42ddf376-8dc0-4236-be2a-0c6ae92ece04","title":"TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM) TABLET, FILM COATED [CURRAX PHARMACEUTICALS LLC]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T00:14:23.850Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[],"indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07103694","phase":"","title":"i-NEED: NEw migrainE Drugs Database","status":"RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2022-03-24","conditions":"Episodic Migraine, Chronic Migraine, Medication Overuse Headache","enrollment":2641},{"nctId":"NCT06868953","phase":"","title":"Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study","status":"NOT_YET_RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2025-04-10","conditions":"Migraine","enrollment":300},{"nctId":"NCT05854992","phase":"","title":"Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-07-05","conditions":"Migraine, Cardiovascular Diseases, Pregnancy","enrollment":68419},{"nctId":"NCT04948164","phase":"PHASE3","title":"Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2018-08-01","conditions":"Migraine in Adults","enrollment":240},{"nctId":"NCT01053507","phase":"PHASE4","title":"Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction","status":"TERMINATED","sponsor":"Cady, Roger, M.D.","startDate":"2010-05","conditions":"Post-Traumatic Headache","enrollment":23},{"nctId":"NCT01086358","phase":"PHASE4","title":"Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-09","conditions":"Workplace Migraine Treatment","enrollment":60},{"nctId":"NCT00385008","phase":"PHASE3","title":"TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09-13","conditions":"Migraine Disorders","enrollment":20},{"nctId":"NCT00989625","phase":"PHASE1","title":"A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-04","conditions":"Migraine Disorders","enrollment":50},{"nctId":"NCT01332500","phase":"","title":"Treximet ™ Pharmacy Budget Impact Model Database Validation Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07","conditions":"Migraine Disorders","enrollment":61737},{"nctId":"NCT00488514","phase":"PHASE3","title":"Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-07-13","conditions":"Migraine Disorders","enrollment":656},{"nctId":"NCT00383162","phase":"PHASE3","title":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11","conditions":"Migraine Disorders","enrollment":173},{"nctId":"NCT00382993","phase":"PHASE3","title":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12","conditions":"Migraine Disorders","enrollment":169},{"nctId":"NCT00329355","phase":"PHASE3","title":"Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05","conditions":"Migraine, Migraine Disorders","enrollment":351},{"nctId":"NCT00843024","phase":"PHASE3","title":"Migraine Study in Adolescent Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-12","conditions":"Migraine Disorders","enrollment":589},{"nctId":"NCT00387881","phase":"PHASE3","title":"TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09","conditions":"Migraine, Without Aura","enrollment":679},{"nctId":"NCT00792636","phase":"PHASE4","title":"A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11","conditions":"Migraine Disorders","enrollment":407},{"nctId":"NCT00240617","phase":"PHASE3","title":"Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Migraine Disorders","enrollment":623},{"nctId":"NCT00329459","phase":"PHASE3","title":"Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05","conditions":"Migraine Disorders","enrollment":320},{"nctId":"NCT01138150","phase":"PHASE4","title":"Ictal and Interictal Inflammatory Markers in Migraine","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-09","conditions":"Migraine","enrollment":36},{"nctId":"NCT01016678","phase":"PHASE2, PHASE3","title":"Treximet Early Intervention Adolescent Migraine","status":"COMPLETED","sponsor":"Premiere Research Institute","startDate":"2010-03","conditions":"Migraine","enrollment":104},{"nctId":"NCT00240630","phase":"PHASE3","title":"Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Migraine Disorders, Migraine","enrollment":646},{"nctId":"NCT00893594","phase":"NA","title":"Efficacy of Sumatriptan With Naprosyn in Migraine With Aura","status":"UNKNOWN","sponsor":"Dent Neurologic Institute","startDate":"2010-10","conditions":"Migraine With Aura","enrollment":30},{"nctId":"NCT01059604","phase":"","title":"Sumatriptan and Naratriptan Pregnancy Registry","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-12","conditions":"Migraine Disorders","enrollment":868},{"nctId":"NCT01329562","phase":"PHASE4","title":"CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2011-05","conditions":"Menstrual Migraine","enrollment":41},{"nctId":"NCT01916395","phase":"","title":"Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache","status":"COMPLETED","sponsor":"Gary E. Ruoff, M.D.","startDate":"2009-12","conditions":"Migraine","enrollment":30},{"nctId":"NCT01090050","phase":"PHASE4","title":"Treximet in the Treatment of Chronic Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2010-09","conditions":"Chronic Migraine","enrollment":56},{"nctId":"NCT01300546","phase":"PHASE4","title":"Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2010-12","conditions":"Migraine","enrollment":40},{"nctId":"NCT01381523","phase":"","title":"A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11","conditions":"Migraine Disorders","enrollment":1},{"nctId":"NCT01578941","phase":"PHASE4","title":"An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2011-01","conditions":"Menstrual Migraine","enrollment":12},{"nctId":"NCT01112553","phase":"","title":"Treximet Migraine Brain Imaging Research Study","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2010-04","conditions":"Acute Migraine","enrollment":2},{"nctId":"NCT01381497","phase":"","title":"Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-03","conditions":"Migraine Disorders","enrollment":1},{"nctId":"NCT01450995","phase":"PHASE4","title":"Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex","status":"COMPLETED","sponsor":"Stephen H. Landy, M.D.","startDate":"2009-12","conditions":"Migraine","enrollment":50},{"nctId":"NCT00893737","phase":"PHASE4","title":"\"Completeness of Response\" Following Treatment With Treximet™ for Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2009-06","conditions":"Migraine","enrollment":147},{"nctId":"NCT00573170","phase":"PHASE3","title":"TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02","conditions":"Migraine Disorders, Migraine, Acute","enrollment":375},{"nctId":"NCT00837044","phase":"NA","title":"Treximet in Acute Migraine Headache: Assessing Cognitive Function","status":"UNKNOWN","sponsor":"Neurological Research Center","startDate":"2009-02","conditions":"Migraine Headache, Cognitive Impairment","enrollment":30},{"nctId":"NCT00442221","phase":"PHASE3","title":"The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months","status":"COMPLETED","sponsor":"POZEN","startDate":"2004-05","conditions":"Migraine Headaches","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20140513","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20110923","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20111114","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20241121","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20210428","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20160509","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20150514","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20120301","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20081017","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20080415","type":"ORIG","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20210428","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20190722","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"},{"date":"20150514","type":"SUPPL","sponsor":"CURRAX","applicationNumber":"NDA021926"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Treximet","genericName":"Treximet","companyName":"Stephen H. Landy, M.D.","companyId":"stephen-h-landy-m-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}